Harnessing the Power of the Microbiome in Your Skincare: Myths and Facts

One of the dominant marketing strategies currently employed by the cosmetics industry is the push towards ‘evidence based’ actives. Whilst all will agree that scientific evidence forms an integral part of a skin professionals decision making, we often focus solely on the actives, but totally overlook the base in which they are formulated. Cliche claims such as ‘no nasties’ and ‘free from’, are not sufficient for sound decision-making required by a skincare professional. As our understanding of the skin microbiome gathers pace, it is apparent that correctly formulated bases could in fact be more important for skin health than the active itself. It is time to move beyond simply evidence-based actives and towards evidence-based actives in evidence-based microbiome-friendly bases. 

In this lecture you will learn:

  • Why active ingredients are the least important factor to consider
  • The importance of the formulation’s base and what to look for
  • How to determine if your formula is harnessing the power of the microbiome in your choice of skincare
  • The importance of fatty acids in a formula
  • The link between skin pH and microbiome health
About Ben Eshelby

Ben is a compounding pharmacist and formulating chemist who is passionate about shaking up the pharmacy, healthcare and personal care industries through community pharmacy-based compounding that is compliant to the latest evidence-based science. Whilst he has a deep understanding of the health benefits that compounding may have for an individual, his specialty is the skin and in creating dermatological products that foster a healthy human skin microbiome. As the personal care and cosmetics industry gradually evolves to embrace sound medical, evidence-bases data, Ben is showing that skincare made in a microbiome-friendly manner can in fact greatly enhance clinical results.

After graduating from the University of Queensland, Ben then spent a significant amount of time working as a registered pharmacist in England, Scotland and Wales. Upon returning to Australia, he noticed the same large gaps in pharmaceutical treatments existed.  He is involved in formulating skin products for use in clinical trials, and is a regular lecturer to medical professions, as well as has written papers on the skin’s microbiome as a therapeutic target and the importance of correct formulations.